Cord and Placenta Blood Banking Overview
There's only one opportunity to save your baby's stem cells for the future...
As an expectant parent, your baby's health means everything. Right now, he or she is protected in the womb and will soon enter the world. There is a lot to think about and prepare for, but an invaluable step you can take when your child is born is to preserve his/her stem-cell rich cord and placenta blood. The ability of stem cells to save lives via cord blood banking has proven successful for replacing abnormal or diseased cells, and treating life-threatening blood disorders such as leukemia, lymphoma, and myeloma. In fact, since 1988 stem cell transplants have been used to treat some 80 diseases!1,2.
Cord Blood Banking + Placenta Blood Banking = A LifebankUSA Advantage
Stem cells are saving and improving more lives every day. And banking cord and placenta blood with LifebankUSA gives your family more of these potentially lifesaving cells. LifebankUSA collects stem cells from two prenatal sources of stem cell-rich blood: the umbilical cord and the placenta. Stem cells collected from both sources have been used for transplants, and only LifebankUSA is registered with the FDA for both products.
Compared to cord blood banking alone, placental & cord blood banking yields 41% more of a particular type of cell called a CD34+ stem cell.3 Studies have shown that using more CD34+ stem cells can lead to a significant survival advantage in transplant patients.4,5 Please click here for more information on CD34+ cells.
Placental and cord blood also contain mesenchymal* - like cells,6 which may prove valuable in new treatments that may emerge.6-9 Please click here for more information on mesenchymal-like stem cells.
†† Data on file.
Stem cells from placental and cord blood are indicated to rebuild blood. View Product Information.
- The Leukemia & Lymphoma Society. Cord blood stem cell transplantation. No. 2. LINK Accessed January 31, 2013.
- St. Jude Children's Research Hospital. Diseases treated by stem cell transplant. St. Jude Children's Research Hospital. Diseases treated by stem cell transplant. LINK. Accessed January 31, 2013.
- Data on file A, LifebankUSA; 2010.
- Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100(5):1611-1618.
- Styczynski J, Cheung Y-K, Garvin J, et al. Unrelated donor transplants: outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant. 2004;34(2):129-136.
- Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol. 2009;147(2):177-184.
- Richardson SM, Hoyland JA, Mobasheri R, Csaki C, Shakibaei M, Mobasheri A. Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering. J Cell Physiol. 2010;222(1):23-32.
- Yen BL, Huang H-I, Chien C-C, et al. Isolation of multipotent cells from human term placenta. Stem Cells. 2005;23(1):3-9.
- Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S. Mesenchymal Stem Cells for Bone Repair and Metabolic Bone Diseases. Mayo Clin Proc. 2009;84(10):893-902.